Core Insights - The report highlights the optimistic attitude of Chinese patients towards AI in healthcare, with 89% believing it enhances care quality, significantly higher than the global average of 59% [1][2] - AI is driving a transformation in China's healthcare model from "passive treatment" to "active health management," with 84% of healthcare professionals recognizing its role in early intervention [2][3] Group 1: Patient and Professional Perspectives - 90% of Chinese patients are willing to embrace technology that improves healthcare accessibility, compared to a global average of 72% [2] - 84% of Chinese healthcare professionals believe AI can play a crucial role in early intervention, and 77% think it can reduce future hospitalization rates [2][3] - Trust issues remain a challenge, with about two-thirds of patients concerned that digital technology may compromise the "human touch" in healthcare [2] Group 2: Trust Building and Systemic Challenges - The most trusted information sources for patients are doctors (96%), healthcare systems (96%), and nurses (95%) [3] - Healthcare professionals identify systemic issues such as legal liability (43%), data bias and quality (41%), and scientific validity (39%) as key areas to enhance trust [3] Group 3: AI Development and Future Trends - The demand for AI in China is described as "rigid" due to the large population and uneven distribution of medical resources [4] - Future AI systems are expected to transition from "point solutions" to "full-process coverage," particularly in imaging, requiring the development of specialized models for various medical fields [4] - Philips invests 9% of its annual revenue in innovation, with half allocated to digital and AI technologies, having registered over 1,000 AI-related intellectual properties [5] Group 4: Collaborative Ecosystem and Global Strategy - The shift in global medical innovation paradigms emphasizes the need for clinical data integration to achieve "implementable AI" [5] - Continuous policy optimization and technological iteration are positioning China as an "ecosystem builder" in healthcare AI, with a clear consensus on the necessity of technology, trust, and collaboration to reshape the future of healthcare [5]